PINK1 stimulators (NINDS)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NamePINK1 stimulators (NINDS)
Drug Alias NamePTEN-induced putative kinase 1-based therapy (NINDS)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerine/threonine-protein kinase PINK1, mitochondrial activators
TargetsSerine/threonine-protein kinase PINK1, mitochondrial
Therapy Area/IndicationsMitochondrial DiseasesParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNational Institute Of Neurological Disorders And Stroke
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNational Institutes Of HealthNational Institute Of Neurological Disorders And Stroke
Active IndicationsN/A
Inactive IndicationsMitochondrial DiseasesParkinson Disease

Other Information

ATC CodeN/A
Related LinksN/A